chartexchange

BCDA
BioCardia, Inc. Common Stock
stockNASDAQ

At CloseNov 17, 2026 3:59:43 PM EST
0.78USD-1.886%(-0.01)41,869
Pre-marketNov 17, 2026 8:54:30 AM EST
0.815USD+3.151%(+0.025)
After-hoursNov 17, 2026 4:00:30 PM EST
0.7882USD+1.677%(+0.013)
0.6600Bid0.9300Ask0.2700Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Sunnyvale, CA, USA
Previous Close
$0.79
Beta
0.51
52-Week High
$1.80 2026-06-05
52-Week Low
$0.66 2026-11-12
SMA 50
$1.00
SMA 200
$1.05
Avg. Vol 10D
113,827
Avg. Vol 30D
119,958
Avg. Vol 90D
229,799
Relative Vol
0.34
12.30M
4.6600%
4,366
May 30, 2024 · 1-for-15 (reverse)
BCDA Profile

we are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. biocardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its cardiamp™ and cardiallo™ therapies. clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. these programs are enabled by the company's helix™ transendocardial delivery systems and morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.

BCDA Performance
PeriodPriceDateChangeBeta
1W0.932026-11-10-17.47%1.254
1M0.922026-10-16-16.56%1.308
3M0.942026-08-17-18.33%0.612
6M0.902026-05-18-14.71%0.141
1Y1.222025-11-17-37.07%0.511
2Y2.052024-11-18-62.55%—
5Y34.802021-11-17-97.79%0.755
BCDA Stock Summary

BioCardia, Inc. Common Stock (NASDAQ:BCDA) stock price today is $0.77, and today's volume is 40,560. BCDA is down 2.835% today. The 30 day average volume is 119,958. BCDA market cap is $11.62M with 15.14M shares outstanding.